Antithrombotic therapy for live birth in women with recurrent pregnancy loss: do not confound available high-level evidence

Hum Reprod. 2021 Dec 27;37(1):190-191. doi: 10.1093/humrep/deab247.

Authors

Luuk J J Scheres^{1

2}, Saskia Middeldorp¹, Mariëtte Goddijn³

Affiliations

¹ Department of Internal Medicine & Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, the Netherlands.
² Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
³ Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

PMID: 34791264
DOI: 10.1093/humrep/deab247

No abstract available

Publication types

Comment

MeSH terms

Abortion, Habitual* / prevention & control
Birth Rate
Female
Fibrinolytic Agents / therapeutic use
Humans
Live Birth*
Pregnancy
Pregnancy, Multiple

Substances

Fibrinolytic Agents